Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| My Size, Inc.MYSZ · Entity 8556 | Director · Chief Executive Officer | December 29, 2025 | December 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
My Size, Inc.
Report date December 29, 2025 · Filed December 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 293,085 |
Reported balance
After 2025-12-29 transaction · row 1
1 source rowRow 1 · 2025-12-29 · Purchase · Acquired 3,750 · Balance 293,085 F1: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.77 to $0.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.77 to $0.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 29, 2025 Filed Dec 30, 2025 10:05 UTC | My Size, Inc. MYSZ · Entity 8556 | PurchaseCommon Stock | 3,750 | $0.78 | $2,925.00 |
DisclosureSEC source: 0001493152-25-029521 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,085 F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.77 to $0.79 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028147 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 79,750 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F5 · shares: 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. F6 · shares: Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. F7 · ownership.nature: Common stock beneficially owned by Reporting Perosn's Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the Plan. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 16:15 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 215,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-028147 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,335 F1 · shares: Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). F2 · shares: 75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F3 · shares: Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date. F4 · shares: 15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 12:48 UTC | My Size, Inc. MYSZ · Entity 8556 | PurchaseCommon Stock | 2,600 | $0.91 | $2,353.00 |
DisclosureSEC source: 0001493152-25-025691 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,335 F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 25, 2025 Filed Nov 26, 2025 11:05 UTC | My Size, Inc. MYSZ · Entity 8556 | PurchaseCommon Stock | 14,000 | $0.90 | $12,530.00 |
DisclosureSEC source: 0001493152-25-025078 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,735 F2 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.83 to $0.96 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 24, 2025 Filed Nov 26, 2025 11:05 UTC | My Size, Inc. MYSZ · Entity 8556 | PurchaseCommon Stock | 235 | $0.89 | $207.98 |
DisclosureSEC source: 0001493152-25-025078 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,735 F1 · price: The reported price is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $0.88 to $0.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 08:55 UTC | My Size, Inc. MYSZ · Entity 8556 | PurchaseCommon Stock | 3,000 | $0.77 | $2,310.00 |
DisclosureSEC source: 0001493152-25-024553 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,500 Read SEC document |
| November 20, 2025 Filed Nov 21, 2025 08:55 UTC | My Size, Inc. MYSZ · Entity 8556 | PurchaseCommon Stock | 10,500 | $0.76 | $7,980.00 |
DisclosureSEC source: 0001493152-25-024553 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,500 Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 650 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 650 Underlying: Common Stock, $.001 par value per share · 650 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 650 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 650 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 800 | Not disclosed Strike: $1.28 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800 Underlying: Common Stock, $.001 par value per share · 800 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 16:10 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 800 | Not disclosed Strike: $8.72 | Not disclosed |
DisclosureSEC source: 0001641172-25-014034 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 800 shares Expires 2025-08-10 F2 · price: Effective June 4, 2025, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.28 per share, which is the closing price of the Company's common stock on June 4, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC | My Size, Inc. MYSZ · Entity 8556 | SaleCommon Stock | 2,000 | $5.10 | $10,200.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 19,750 F1 · ownership.nature: Common stock beneficially owned by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC | My Size, Inc. MYSZ · Entity 8556 | SaleCommon Stock | 2,000 | $5.40 | $10,800.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,000 Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC | My Size, Inc. MYSZ · Entity 8556 | SaleCommon Stock | 2,000 | $5.10 | $10,200.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,000 Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 16:15 UTC | My Size, Inc. MYSZ · Entity 8556 | SaleCommon Stock | 2,000 | $5.12 | $10,240.00 |
DisclosureSEC source: 0001493152-25-000064 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,000 Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007016 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 174,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. F2 · ownership.nature: Common stock beneficially owned by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 16:20 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-007016 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2025, January 1, 2026 and January 1, 2027, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| November 29, 2023 Filed Dec 4, 2023 16:15 UTC | My Size, Inc. MYSZ · Entity 8556 | SaleCommon Stock | 4,683 | $0.68 | $3,202.24 |
DisclosureSEC source: 0001493152-23-043558 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 F1 · shares: The reported sale of 4,683 shares of the issuer's common stock occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023. F1 · ownership.direct: The reported sale of 4,683 shares of the issuer's common stock occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 894 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 8 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 894 Underlying: Common Stock, $.001 par value per share · 894 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 894 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 7 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 894 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 6 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 5,200 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 5,200 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 5 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 5,200 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 1,601 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,601 Underlying: Common Stock, $.001 par value per share · 1,601 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 1,601 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 1,601 shares Expires 2024-05-29 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 6,400 | Not disclosed Strike: $1.09 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,400 Underlying: Common Stock, $.001 par value per share · 6,400 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 17:05 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 6,400 | Not disclosed Strike: $26.00 | Not disclosed |
DisclosureSEC source: 0001493152-23-024752 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 6,400 shares Expires 2025-08-10 F2 · price: Effective July 13, 2023, the Board of Directors of the Company approved a unilateral option repricing, which resulted in the reduction of the exercise price to $1.09 per share, which is the closing price of the Company's common stock on July 13, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 16:30 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027433 · ownership.xml · nonDerivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 600,000 F2 · ownership.nature: Common stock beneficially owned by Spouse (Chief Operating Officer Billy Pardo) under the My Size, Inc. 2017 Equity Incentive Plan. Read SEC document |
| September 29, 2022 Filed Oct 3, 2022 16:30 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantCommon Stock | 2,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-027433 · ownership.xml · nonDerivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,617,064 F1 · shares: Restricted stock granted under the My Size, Inc. 2017 Equity Incentive Plan, which vests in three equal annual installments, with 1/3 vesting on each of January 1, 2023, January 1, 2024 and January 1, 2025, subject to the Reporting Person continuously providing services to the Issuer as an employee through such vesting date. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 16:30 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 130,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001213900-20-021629 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 130,000 Underlying: Common Stock, $.001 par value per share · 130,000 shares Expires 2025-08-10 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. The option vests and becomes exercisable as to one-quarter of the total shares on each of November 26, 2020, May 26, 2021, November 26, 2021, and May 26, 2022. F2 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 16:30 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 160,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001213900-20-021629 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock, $.001 par value per share · 160,000 shares Expires 2025-08-10 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which no options have vested to date. The option vests and becomes exercisable as to one-quarter of the total shares on each of November 26, 2020, May 26, 2021, November 26, 2021, and May 26, 2022. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 17,000 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 12 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,000 Underlying: Common Stock, $.001 par value per share · 17,000 shares Expires 2025-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F4 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on January 24, 2019, one third of the total shares vested on January 24, 2020 and the remaining one third of the total shares vests on January 24, 2021. F5 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 17,000 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 11 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 17,000 shares Expires 2024-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F4 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on January 24, 2019, one third of the total shares vested on January 24, 2020 and the remaining one third of the total shares vests on January 24, 2021. F5 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 5,334 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 10 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,334 Underlying: Common Stock, $.001 par value per share · 5,334 shares Expires 2025-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F5 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 5,334 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 9 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 5,334 shares Expires 2024-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F5 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 8 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2023-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F5 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 10,000 | Not disclosed Strike: $18.15 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 7 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2022-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. F5 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 33,334 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 6 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock, $.001 par value per share · 33,334 shares Expires 2025-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F4 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on January 24, 2019, one third of the total shares vested on January 24, 2020 and the remaining one third of the total shares vests on January 24, 2021. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 33,334 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 5 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 33,334 shares Expires 2024-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F4 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on January 24, 2019, one third of the total shares vested on January 24, 2020 and the remaining one third of the total shares vests on January 24, 2021. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 6,667 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,667 Underlying: Common Stock, $.001 par value per share · 6,667 shares Expires 2025-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 6,667 | Not disclosed Strike: $11.40 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 6,667 shares Expires 2024-05-29 F3 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 10,000 | Not disclosed Strike: $1.04 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2023-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| May 25, 2020 Filed Jun 8, 2020 17:59 UTC | My Size, Inc. MYSZ · Entity 8556 | Disposition to issuerOption to purchase Common Stock (right to buy) · Derivative | 10,000 | Not disclosed Strike: $18.15 | Not disclosed |
DisclosureSEC source: 0001213900-20-014434 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.001 par value per share · 10,000 shares Expires 2022-07-24 F2 · price: Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged. F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 255,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 4 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 255,000 Underlying: Common Stock, $.001 par value per share · 255,000 shares Expires 2024-05-30 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. The option vested and became exercisable as to one-third of the total shares on January 24, 2019 and vests and becomes exercisable as to one third of the total shares on January 24, 2020 and as to the remaining shares on January 24, 2021. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 80,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 3 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 80,000 Underlying: Common Stock, $.001 par value per share · 80,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo). Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 500,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock, $.001 par value per share · 500,000 shares Expires 2024-05-30 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. The option vested and became exercisable as to one-third of the total shares on January 24, 2019 and vests and becomes exercisable as to one third of the total shares on January 24, 2020 and as to the remaining shares on January 24, 2021. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 21:32 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 100,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001213900-19-009987 · ownership.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock, $.001 par value per share · 100,000 shares Expires 2024-05-30 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan. All options vested immediately upon grant. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:51 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007934 · f4072417luzonronen_mysize.xml · derivative · entry 2 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 150,000 Underlying: Common Stock, $.001 par value per share · 150,000 shares Expires 2022-07-24 F2 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, none of which options have vested. All of such options shall vest on January 24, 2018. F3 · ownership.direct: Options acquired by Spouse (Chief Product Officer Billy Luzon). F3 · ownership.nature: Options acquired by Spouse (Chief Product Officer Billy Luzon). Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 16:51 UTC | My Size, Inc. MYSZ · Entity 8556 | GrantOption to purchase Common Stock (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.21 | $0.00 |
DisclosureSEC source: 0001213900-17-007934 · f4072417luzonronen_mysize.xml · derivative · entry 1 Luzon Ronen · CIK 0001686315 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock, $.001 par value per share · 150,000 shares Expires 2022-07-24 F1 · derivative.exercise_date: Option grant under the My Size, Inc. 2017 Equity Incentive Plan, none of which options have vested. All of such options shall vest on January 24, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.